Integrated radio-theranostics using a [(89)Zr]Zr-/[(177)Lu]Lu-labeled B7-H3 antibody-drug conjugate for prostate cancer.

Qiu Y, Gu T, Wang T, Mulati Y, Sun X, Yang Q, Song L, Yuan T, Fan Y, Kang L, Cai W

Open source

DOI
10.7150/thno.125878
Published
2026
Container
Theranostics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7150/thno.125878,
  title = {Integrated radio-theranostics using a [(89)Zr]Zr-/[(177)Lu]Lu-labeled B7-H3 antibody-drug conjugate for prostate cancer.},
  author = {Qiu Y and Gu T and Wang T and Mulati Y and Sun X and Yang Q and Song L and Yuan T and Fan Y and Kang L and Cai W},
  year = {2026},
  journal = {Theranostics},
  doi = {10.7150/thno.125878},
  url = {https://doi.org/10.7150/thno.125878}
}

RIS

TY  - JOUR
TI  - Integrated radio-theranostics using a [(89)Zr]Zr-/[(177)Lu]Lu-labeled B7-H3 antibody-drug conjugate for prostate cancer.
AU  - Qiu Y
AU  - Gu T
AU  - Wang T
AU  - Mulati Y
AU  - Sun X
AU  - Yang Q
AU  - Song L
AU  - Yuan T
AU  - Fan Y
AU  - Kang L
AU  - Cai W
PY  - 2026
JO  - Theranostics
DO  - 10.7150/thno.125878
UR  - https://doi.org/10.7150/thno.125878
ER  - 

APA

Y, Q., T, G., T, W., Y, M., X, S., Q, Y., L, S., T, Y., Y, F., L, K., & W, C. (2026). Integrated radio-theranostics using a [(89)Zr]Zr-/[(177)Lu]Lu-labeled B7-H3 antibody-drug conjugate for prostate cancer.. Theranostics. https://doi.org/10.7150/thno.125878

Source records